• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICRUS ENDOVASCULAR, LLC UNKNOWN HELIPAQ CERECYTE MICROCOIL; CNV DCS COILS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICRUS ENDOVASCULAR, LLC UNKNOWN HELIPAQ CERECYTE MICROCOIL; CNV DCS COILS Back to Search Results
Catalog Number UNKHELIPAQ
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Nerve Damage (1979)
Event Date 08/03/2010
Event Type  Injury  
Event Description
As reported via the (b)(4) study, (b)(6) a patient experienced left cranial nerve palsy (3rd nerve palsy) after 8 cerecyte coils (4 presidio, 3 helipaq, and 1 cashmere) were implanted.Prior to the index procedure, the patient had presented with a large unruptured, asymptomatic aneurysm of the basilar tip with mrs of 0.An adjunctive stent was placed in the artery prior to coil treatment of the regular shaped aneurysm (15 mm high; 15 mm wide with 10 mm neck).Following coiling, residual filling of the neck was observed by angiographic assessment.No events were reported during the procedure.Patient developed l cranial nerve palsy (3rd nerve palsy) post procedure due to the size and location of the aneurysm.At the time of discharge, palsy continued to persist.The patient was discharged 2 days after the index procedure with mrs 3.The investigator indicated the palsy was moderate and related to the procedure.At the time of the 1-month follow-up mrs had dropped to 2.A ct scan showed ¿post interventional changes following stent assisted coiling of basilar apex aneurysm.These findings are unchanged from (b)(6) 2010.No acute intracranial findings¿.The patient was advised to see an ophthalmologist.At the time of the 6-month follow-up visit, the subject¿s mrs was 0, so the palsy had apparently resolved.
 
Manufacturer Narrative
(b)(6).Complaint conclusion: since the coils were implanted, they were not available for analysis.In addition, the lot number was not provided; therefore, a review of the manufacturing documentation could not be provided.Neurological deficit is a known potential adverse event for intracranial coils and is listed in the instructions for use (ifu) as such.The root cause of the event cannot be confirmed.Based on the information provided, there were no product malfunctions or procedural events related to the coils, therefore, no corrective actions will be taken at this time.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNKNOWN HELIPAQ CERECYTE MICROCOIL
Type of Device
CNV DCS COILS
Manufacturer (Section D)
MICRUS ENDOVASCULAR, LLC
821 fox lane
san jose CA 95131
Manufacturer (Section G)
CODMAN AND SHURTLEFF, INC
325 paramount drive
raynham MA 02767
Manufacturer Contact
duane durbin
miami lakes, FL 33014
5088283106
MDR Report Key4074129
MDR Text Key20781310
Report Number1226348-2014-00446
Device Sequence Number1
Product Code HCG
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K022420
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Health Professional
Type of Report Initial
Report Date 02/14/2011
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/09/2014
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNKHELIPAQ
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/14/2011
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Disability;
Patient Age72 YR
-
-